Transforming Research & Development with Faster, More Precise Spatial Insights

*Free to Attend for Drug Developers & Researchers

Welcome to the 3rd Spatial Biology for Drug Development Summit

Successfully De-risk Clinical Decision-Making, Standardize Spatial Biology Applications & Navigate Infrastructure & Data Challenges to Accelerate Workflows with Greater Accuracy & Return on Investment

As spatial biology technology advances, delivering unprecedented resolution, multiplexing, and reproducibility, new insights into disease biology are driving major breakthroughs across multiple therapeutic areas. Yet, key barriers still limit the full application of spatial biology in drug development. Overcoming these challenges is critical to achieving widespread adoption in research settings and beyond.

The 3rd Spatial Biology for Drug Development Summit is your opportunity to come together with leading biopharma experts to address these hurdles head-on. Across an intensive 2-day agenda, you’ll explore practical solutions to issues spanning data infrastructure, multi-omics integration, standardization, scalability, and translation into the clinic. This year’s forum will equip you with the latest data-driven strategies to not only overcome obstacles but to maximize the value of spatial biology for deeper disease insights, robust target identification, biomarker discovery, and more.

"This conference offers a unique opportunity for biopharma professionals to stay at the forefront of spatial molecular technology, deepen their understanding of disease, develop new therapeutics, and contribute to the advancement of precision medicine."

Director II, AbbVie 

AbbVie

Download the Full Event Guide to Discover:

  • 18+ Expert Speakers delivering high-impact insights, practical experience and future-focused perspectives.
  • 14+ Case Studies showcasing fresh data and proven strategies to help you maximise the value of spatial biology across your pipeline.
  • 8+ Hours of Dedicated Networking giving you ample time to connect with peers, benchmark progress, and spark new collaborations.
  • 4+ Panel & Discussion Sessions providing open forums to tackle practical challenges, share diverse viewpoints, and define clear actions for scaling spatial biology in drug development.
Screenshot 2025-07-15 162505

World-Class Speaker Faculty Includes:

Subba Chintalacharuvu, Executive Director - Translational Immunology, Genentech

Subba Chintalacharuvu

Executive Director - Translational Immunology

Genentech

Timothy Holzer, Executive Director, Clinical Diagnostics Laboratory, Eli Lilly

Tim Holzer

Executive Director, Clinical Diagnostics Laboratory

Eli Lilly

Vanessa King, Director - Companion Diagnostics, Daiichi Sankyo

Vanessa M. King

Director - Companion Diagnostics

Daiichi Sankyo

William Hwang, Assistant Professor - Principal Investigator, Massachusetts General Hospital, Harvard Medical School

William Hwang

Assistant Professor - Principal Investigator

Massachusetts General Hospital, Harvard Medical School

Ying Zhang, Head - Next Generation Sequencing, Systems & Immunology Group, Pfizer

Ying Zhang

Head - Next Generation Sequencing, Systems & Immunology Group

Pfizer

Previously Attending Companies Include:

“Attending conferences like the 3rd Spatial Biology for Drug Development Summit offers valuable opportunities to stay current with emerging technologies, gain insights into translational applications, network with industry leaders, and explore potential collaborations that can accelerate drug development efforts.”

Associate Director – Spatial Transcriptomics, Takeda

Explore Related Events